Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
3.390
+0.020 (0.59%)
Nov 21, 2024, 12:17 PM EST - Market open

Mural Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
46.8840.9127.6325.25
Research & Development
112.44153.73157.29150.12
Operating Expenses
159.32194.64184.92175.37
Operating Income
-159.32-194.64-184.92-175.37
Other Non Operating Income (Expenses)
9.120.95--
EBT Excluding Unusual Items
-150.2-193.69-184.92-175.37
Merger & Restructuring Charges
-1.6-1.6--
Pretax Income
-151.8-195.29-184.92-175.37
Income Tax Expense
1.9812.164.880.07
Net Income
-153.78-207.45-189.81-175.43
Net Income to Common
-153.78-207.45-189.81-175.43
Shares Outstanding (Basic)
171717-
Shares Outstanding (Diluted)
171717-
Shares Change (YoY)
1.02%---
EPS (Basic)
-9.12-12.43-11.37-
EPS (Diluted)
-9.12-12.43-11.37-
Free Cash Flow
-140.75-197.7-174.1-161.05
Free Cash Flow Per Share
-8.35-11.85-10.43-
EBITDA
-156.06-192.07-183.38-173.89
D&A For EBITDA
3.262.571.541.47
EBIT
-159.32-194.64-184.92-175.37
Source: S&P Capital IQ. Standard template. Financial Sources.